Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Opportunistic Infections
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyCell therapyPhase 2/3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Opportunistic Infections cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →